Researchers studying the emerging field of triple agonism and glucagon's role in metabolic regulation may prefer retatrutide, the most novel compound of the three
Retatrutide is a newer injectable that targets three hormonesGLP-1, GIP, and glucagonto help regulate appetite, metabolism, and blood sugar
Besides, dual GLP-1/GIP receptor agonists (DA-JC4, DA5-CH, DA-JC1 and DA-CH3) reduced inflammation response, amyloid plaques and tau phosphorylation in brain, reversed memory loss, and enhanced synaptic plasticity in hippocampus of APP/PS1 mice (186, 234, 236, 238)
Glucagon promotes lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol
These included: Nausea (most frequently reported) Vomiting Diarrhoea Constipation Decreased appetite These effects were generally dose-dependent and transient , tending to occur during the dose escalation phase and resolving or diminishing over time
To date, only a few studies have focused on the effects of food patterns on GLP-1 secretion and thus on metabolism, the immune system, and the microbiota-gut-brain axis [79,176,177]
